EMA/PE/0000226763 - paediatric investigation plan
tofacitinib citrate
PIPHuman
Croatian is available via eTranslation, the European Commission's machine translation service.
Translate to Croatian | Important information about machine translation
Key facts
- Invented name
- Xeljanz
- Active substance
- tofacitinib citrate
- Therapeutic area
- Gastroentology-Hepatology
- Decision number
- EMA/PE/0000226763
- PIP number
- EMA/PE/0000226763
- Pharmaceutical form(s)
- Film-coated tablet
- Oral solution
- Condition(s) / indication(s)
- Treatment of ulcerative colitis
- Route(s) of administration
- Oral use
- Contact for public enquiries
Pfizer Europe MA EEIG
Tel. +44 (0)1304 646 607
E-mail: pip_enquiries@pfizer.com- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date
- Compliance check done
- Ne